The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...
Emerging tools enable more accurate antigen production and presentation using mRNA instead of protein. In recent years, mRNA technology has come into its own, most prominently in the field of vaccine ...
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...
Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
WHO warns of ‘concerning’ Covid trends ahead of winter Billions of Pfizer/BioNTech and Moderna ... the first vaccines to use the mRNA technology came out just three years ago.